TXNDC5 is involved in reducing the efficiency of photothermal therapy, a minimally invasive and highly specific antineoplastic treatment, by resisting oxidative stress damage and promoting tumor growth and metastasis [128]. The gene discussed is TXNDC5; the disease is neoplasm.